From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
D000881:Anthrax / Q000517:prevention & control*; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis / Q000009:adverse effects*; D001408:Bacillus anthracis; D023482:Bioterrorism; D002939:Ciprofloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D004219:District of Columbia; D004318:Doxycycline / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009515:New Jersey; D009519:New York City; D009784:Occupational Diseases / Q000517:prevention & control*; D016273:Occupational Exposure; D011177:Postal Service; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D017192:Skin Diseases, Bacterial / Q000517:prevention & control; D013171:Spores, Bacterial
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D004318:Doxycycline